nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—CYP2C9—cardial valve—systemic scleroderma	0.0208	0.79	CbGeAlD
Glimepiride—ABCC8—smooth muscle tissue—systemic scleroderma	0.00255	0.0969	CbGeAlD
Glimepiride—KCNJ11—tendon—systemic scleroderma	0.00208	0.079	CbGeAlD
Glimepiride—Pruritus—Mometasone—systemic scleroderma	0.00143	0.00147	CcSEcCtD
Glimepiride—Tachycardia—Leflunomide—systemic scleroderma	0.00143	0.00147	CcSEcCtD
Glimepiride—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00142	0.00146	CcSEcCtD
Glimepiride—Anaemia—Lisinopril—systemic scleroderma	0.00142	0.00146	CcSEcCtD
Glimepiride—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00141	0.00145	CcSEcCtD
Glimepiride—Hepatic failure—Methotrexate—systemic scleroderma	0.00141	0.00145	CcSEcCtD
Glimepiride—Angioedema—Lisinopril—systemic scleroderma	0.00141	0.00145	CcSEcCtD
Glimepiride—Confusional state—Mycophenolic acid—systemic scleroderma	0.00141	0.00144	CcSEcCtD
Glimepiride—Abdominal pain—Captopril—systemic scleroderma	0.0014	0.00144	CcSEcCtD
Glimepiride—Anorexia—Leflunomide—systemic scleroderma	0.00139	0.00143	CcSEcCtD
Glimepiride—Nausea—Pentoxifylline—systemic scleroderma	0.00139	0.00143	CcSEcCtD
Glimepiride—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00142	CcSEcCtD
Glimepiride—Diarrhoea—Mometasone—systemic scleroderma	0.00138	0.00142	CcSEcCtD
Glimepiride—Leukopenia—Lisinopril—systemic scleroderma	0.00138	0.00142	CcSEcCtD
Glimepiride—Shock—Mycophenolic acid—systemic scleroderma	0.00137	0.00141	CcSEcCtD
Glimepiride—Hypotension—Leflunomide—systemic scleroderma	0.00137	0.0014	CcSEcCtD
Glimepiride—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00137	0.0014	CcSEcCtD
Glimepiride—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00136	0.0014	CcSEcCtD
Glimepiride—Palpitations—Lisinopril—systemic scleroderma	0.00136	0.0014	CcSEcCtD
Glimepiride—Loss of consciousness—Lisinopril—systemic scleroderma	0.00135	0.00139	CcSEcCtD
Glimepiride—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00139	CcSEcCtD
Glimepiride—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00135	0.00139	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.00134	0.00138	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00134	0.00137	CcSEcCtD
Glimepiride—Anorexia—Mycophenolic acid—systemic scleroderma	0.00133	0.00137	CcSEcCtD
Glimepiride—Tension—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00136	CcSEcCtD
Glimepiride—Insomnia—Leflunomide—systemic scleroderma	0.00132	0.00136	CcSEcCtD
Glimepiride—Abdominal distension—Prednisone—systemic scleroderma	0.00132	0.00136	CcSEcCtD
Glimepiride—Paraesthesia—Leflunomide—systemic scleroderma	0.00131	0.00135	CcSEcCtD
Glimepiride—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00135	CcSEcCtD
Glimepiride—Anxiety—Lisinopril—systemic scleroderma	0.00131	0.00134	CcSEcCtD
Glimepiride—Dyspnoea—Leflunomide—systemic scleroderma	0.0013	0.00134	CcSEcCtD
Glimepiride—Hypotension—Mycophenolic acid—systemic scleroderma	0.0013	0.00134	CcSEcCtD
Glimepiride—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.0013	0.00133	CcSEcCtD
Glimepiride—Dyspepsia—Leflunomide—systemic scleroderma	0.00129	0.00132	CcSEcCtD
Glimepiride—Vomiting—Mometasone—systemic scleroderma	0.00128	0.00132	CcSEcCtD
Glimepiride—Dry mouth—Lisinopril—systemic scleroderma	0.00128	0.00132	CcSEcCtD
Glimepiride—Sweating increased—Prednisone—systemic scleroderma	0.00128	0.00131	CcSEcCtD
Glimepiride—Feeling abnormal—Azathioprine—systemic scleroderma	0.00128	0.00131	CcSEcCtD
Glimepiride—Rash—Mometasone—systemic scleroderma	0.00127	0.00131	CcSEcCtD
Glimepiride—Asthenia—Captopril—systemic scleroderma	0.00127	0.00131	CcSEcCtD
Glimepiride—Dermatitis—Mometasone—systemic scleroderma	0.00127	0.00131	CcSEcCtD
Glimepiride—Decreased appetite—Leflunomide—systemic scleroderma	0.00127	0.00131	CcSEcCtD
Glimepiride—Confusional state—Lisinopril—systemic scleroderma	0.00127	0.0013	CcSEcCtD
Glimepiride—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00127	0.0013	CcSEcCtD
Glimepiride—Headache—Mometasone—systemic scleroderma	0.00127	0.0013	CcSEcCtD
Glimepiride—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00126	0.0013	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00126	0.0013	CcSEcCtD
Glimepiride—Insomnia—Mycophenolic acid—systemic scleroderma	0.00126	0.0013	CcSEcCtD
Glimepiride—Fatigue—Leflunomide—systemic scleroderma	0.00126	0.00129	CcSEcCtD
Glimepiride—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00126	0.00129	CcSEcCtD
Glimepiride—Pruritus—Captopril—systemic scleroderma	0.00126	0.00129	CcSEcCtD
Glimepiride—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00125	0.00129	CcSEcCtD
Glimepiride—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00128	CcSEcCtD
Glimepiride—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00124	0.00128	CcSEcCtD
Glimepiride—Somnolence—Mycophenolic acid—systemic scleroderma	0.00124	0.00127	CcSEcCtD
Glimepiride—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00127	CcSEcCtD
Glimepiride—Shock—Lisinopril—systemic scleroderma	0.00124	0.00127	CcSEcCtD
Glimepiride—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00127	CcSEcCtD
Glimepiride—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00123	0.00126	CcSEcCtD
Glimepiride—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00123	0.00126	CcSEcCtD
Glimepiride—Tachycardia—Lisinopril—systemic scleroderma	0.00123	0.00126	CcSEcCtD
Glimepiride—Abdominal pain—Azathioprine—systemic scleroderma	0.00122	0.00126	CcSEcCtD
Glimepiride—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00121	0.00125	CcSEcCtD
Glimepiride—Diarrhoea—Captopril—systemic scleroderma	0.00121	0.00125	CcSEcCtD
Glimepiride—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00121	0.00125	CcSEcCtD
Glimepiride—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00124	CcSEcCtD
Glimepiride—Feeling abnormal—Leflunomide—systemic scleroderma	0.00121	0.00124	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.0012	0.00124	CcSEcCtD
Glimepiride—Fatigue—Mycophenolic acid—systemic scleroderma	0.0012	0.00124	CcSEcCtD
Glimepiride—Nausea—Mometasone—systemic scleroderma	0.0012	0.00123	CcSEcCtD
Glimepiride—Anorexia—Lisinopril—systemic scleroderma	0.0012	0.00123	CcSEcCtD
Glimepiride—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.0012	0.00123	CcSEcCtD
Glimepiride—Weight increased—Prednisone—systemic scleroderma	0.00119	0.00123	CcSEcCtD
Glimepiride—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00122	CcSEcCtD
Glimepiride—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00122	CcSEcCtD
Glimepiride—Hypotension—Lisinopril—systemic scleroderma	0.00117	0.00121	CcSEcCtD
Glimepiride—Dizziness—Captopril—systemic scleroderma	0.00117	0.00121	CcSEcCtD
Glimepiride—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00117	0.0012	CcSEcCtD
Glimepiride—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00116	0.0012	CcSEcCtD
Glimepiride—Urticaria—Leflunomide—systemic scleroderma	0.00116	0.00119	CcSEcCtD
Glimepiride—Abdominal pain—Leflunomide—systemic scleroderma	0.00116	0.00119	CcSEcCtD
Glimepiride—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00115	0.00118	CcSEcCtD
Glimepiride—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00118	CcSEcCtD
Glimepiride—Hypersensitivity—Azathioprine—systemic scleroderma	0.00114	0.00117	CcSEcCtD
Glimepiride—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00114	0.00117	CcSEcCtD
Glimepiride—Insomnia—Lisinopril—systemic scleroderma	0.00114	0.00117	CcSEcCtD
Glimepiride—Paraesthesia—Lisinopril—systemic scleroderma	0.00113	0.00116	CcSEcCtD
Glimepiride—Vomiting—Captopril—systemic scleroderma	0.00113	0.00116	CcSEcCtD
Glimepiride—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00115	CcSEcCtD
Glimepiride—Dyspnoea—Lisinopril—systemic scleroderma	0.00112	0.00115	CcSEcCtD
Glimepiride—Rash—Captopril—systemic scleroderma	0.00112	0.00115	CcSEcCtD
Glimepiride—Dermatitis—Captopril—systemic scleroderma	0.00112	0.00115	CcSEcCtD
Glimepiride—Somnolence—Lisinopril—systemic scleroderma	0.00112	0.00115	CcSEcCtD
Glimepiride—Headache—Captopril—systemic scleroderma	0.00111	0.00114	CcSEcCtD
Glimepiride—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00114	CcSEcCtD
Glimepiride—Dyspepsia—Lisinopril—systemic scleroderma	0.00111	0.00114	CcSEcCtD
Glimepiride—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.0011	0.00113	CcSEcCtD
Glimepiride—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00113	CcSEcCtD
Glimepiride—Decreased appetite—Lisinopril—systemic scleroderma	0.00109	0.00112	CcSEcCtD
Glimepiride—Eosinophilia—Methotrexate—systemic scleroderma	0.00109	0.00112	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00108	0.00111	CcSEcCtD
Glimepiride—Fatigue—Lisinopril—systemic scleroderma	0.00108	0.00111	CcSEcCtD
Glimepiride—Shock—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00111	CcSEcCtD
Glimepiride—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00111	CcSEcCtD
Glimepiride—Hypersensitivity—Leflunomide—systemic scleroderma	0.00108	0.00111	CcSEcCtD
Glimepiride—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00107	0.0011	CcSEcCtD
Glimepiride—Bradycardia—Prednisone—systemic scleroderma	0.00107	0.0011	CcSEcCtD
Glimepiride—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00109	CcSEcCtD
Glimepiride—Diarrhoea—Azathioprine—systemic scleroderma	0.00106	0.00109	CcSEcCtD
Glimepiride—Nausea—Captopril—systemic scleroderma	0.00105	0.00108	CcSEcCtD
Glimepiride—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00108	CcSEcCtD
Glimepiride—Asthenia—Leflunomide—systemic scleroderma	0.00105	0.00108	CcSEcCtD
Glimepiride—Pancytopenia—Methotrexate—systemic scleroderma	0.00104	0.00107	CcSEcCtD
Glimepiride—Feeling abnormal—Lisinopril—systemic scleroderma	0.00104	0.00106	CcSEcCtD
Glimepiride—Pruritus—Leflunomide—systemic scleroderma	0.00103	0.00106	CcSEcCtD
Glimepiride—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00106	CcSEcCtD
Glimepiride—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00103	0.00106	CcSEcCtD
Glimepiride—Dizziness—Azathioprine—systemic scleroderma	0.00102	0.00105	CcSEcCtD
Glimepiride—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.001	0.00103	CcSEcCtD
Glimepiride—Asthenia—Mycophenolic acid—systemic scleroderma	0.001	0.00103	CcSEcCtD
Glimepiride—Diarrhoea—Leflunomide—systemic scleroderma	0.001	0.00103	CcSEcCtD
Glimepiride—Urticaria—Lisinopril—systemic scleroderma	0.000998	0.00103	CcSEcCtD
Glimepiride—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000996	0.00102	CcSEcCtD
Glimepiride—Abdominal pain—Lisinopril—systemic scleroderma	0.000993	0.00102	CcSEcCtD
Glimepiride—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000989	0.00102	CcSEcCtD
Glimepiride—Pruritus—Mycophenolic acid—systemic scleroderma	0.000987	0.00101	CcSEcCtD
Glimepiride—Vomiting—Azathioprine—systemic scleroderma	0.000985	0.00101	CcSEcCtD
Glimepiride—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000982	0.00101	CcSEcCtD
Glimepiride—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000979	0.00101	CcSEcCtD
Glimepiride—Drowsiness—Methotrexate—systemic scleroderma	0.000978	0.001	CcSEcCtD
Glimepiride—Rash—Azathioprine—systemic scleroderma	0.000976	0.001	CcSEcCtD
Glimepiride—Dermatitis—Azathioprine—systemic scleroderma	0.000976	0.001	CcSEcCtD
Glimepiride—Headache—Azathioprine—systemic scleroderma	0.00097	0.000996	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00097	0.000996	CcSEcCtD
Glimepiride—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000969	0.000995	CcSEcCtD
Glimepiride—Dizziness—Leflunomide—systemic scleroderma	0.000967	0.000993	CcSEcCtD
Glimepiride—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000957	0.000983	CcSEcCtD
Glimepiride—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000955	0.00098	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000951	0.000976	CcSEcCtD
Glimepiride—Arrhythmia—Prednisone—systemic scleroderma	0.000938	0.000964	CcSEcCtD
Glimepiride—Sweating—Methotrexate—systemic scleroderma	0.000938	0.000963	CcSEcCtD
Glimepiride—Vomiting—Leflunomide—systemic scleroderma	0.00093	0.000955	CcSEcCtD
Glimepiride—Hypersensitivity—Lisinopril—systemic scleroderma	0.000926	0.000951	CcSEcCtD
Glimepiride—Dizziness—Mycophenolic acid—systemic scleroderma	0.000923	0.000948	CcSEcCtD
Glimepiride—Rash—Leflunomide—systemic scleroderma	0.000922	0.000947	CcSEcCtD
Glimepiride—Dermatitis—Leflunomide—systemic scleroderma	0.000921	0.000946	CcSEcCtD
Glimepiride—Nausea—Azathioprine—systemic scleroderma	0.00092	0.000945	CcSEcCtD
Glimepiride—Headache—Leflunomide—systemic scleroderma	0.000916	0.000941	CcSEcCtD
Glimepiride—Erythema—Prednisone—systemic scleroderma	0.000914	0.000939	CcSEcCtD
Glimepiride—Malnutrition—Prednisone—systemic scleroderma	0.000914	0.000939	CcSEcCtD
Glimepiride—Agranulocytosis—Methotrexate—systemic scleroderma	0.000913	0.000937	CcSEcCtD
Glimepiride—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000907	0.000932	CcSEcCtD
Glimepiride—Asthenia—Lisinopril—systemic scleroderma	0.000902	0.000926	CcSEcCtD
Glimepiride—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.0009	0.000925	CcSEcCtD
Glimepiride—CYP2C9—digestive system—systemic scleroderma	0.0009	0.0342	CbGeAlD
Glimepiride—Pruritus—Lisinopril—systemic scleroderma	0.000889	0.000913	CcSEcCtD
Glimepiride—Vomiting—Mycophenolic acid—systemic scleroderma	0.000887	0.000911	CcSEcCtD
Glimepiride—Rash—Mycophenolic acid—systemic scleroderma	0.00088	0.000903	CcSEcCtD
Glimepiride—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000879	0.000903	CcSEcCtD
Glimepiride—Hepatitis—Methotrexate—systemic scleroderma	0.000878	0.000902	CcSEcCtD
Glimepiride—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000875	0.000898	CcSEcCtD
Glimepiride—Headache—Mycophenolic acid—systemic scleroderma	0.000874	0.000898	CcSEcCtD
Glimepiride—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00087	0.000894	CcSEcCtD
Glimepiride—Nausea—Leflunomide—systemic scleroderma	0.000869	0.000892	CcSEcCtD
Glimepiride—Vision blurred—Prednisone—systemic scleroderma	0.000862	0.000885	CcSEcCtD
Glimepiride—Diarrhoea—Lisinopril—systemic scleroderma	0.00086	0.000883	CcSEcCtD
Glimepiride—Visual impairment—Methotrexate—systemic scleroderma	0.000846	0.000869	CcSEcCtD
Glimepiride—Anaemia—Prednisone—systemic scleroderma	0.000845	0.000868	CcSEcCtD
Glimepiride—Agitation—Prednisone—systemic scleroderma	0.00084	0.000863	CcSEcCtD
Glimepiride—Angioedema—Prednisone—systemic scleroderma	0.000836	0.000858	CcSEcCtD
Glimepiride—Dizziness—Lisinopril—systemic scleroderma	0.000831	0.000853	CcSEcCtD
Glimepiride—Erythema multiforme—Methotrexate—systemic scleroderma	0.00083	0.000853	CcSEcCtD
Glimepiride—Nausea—Mycophenolic acid—systemic scleroderma	0.000829	0.000851	CcSEcCtD
Glimepiride—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000811	0.000833	CcSEcCtD
Glimepiride—Loss of consciousness—Prednisone—systemic scleroderma	0.000804	0.000826	CcSEcCtD
Glimepiride—Vomiting—Lisinopril—systemic scleroderma	0.000799	0.000821	CcSEcCtD
Glimepiride—Rash—Lisinopril—systemic scleroderma	0.000792	0.000814	CcSEcCtD
Glimepiride—Convulsion—Prednisone—systemic scleroderma	0.000792	0.000814	CcSEcCtD
Glimepiride—Dermatitis—Lisinopril—systemic scleroderma	0.000792	0.000813	CcSEcCtD
Glimepiride—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00079	0.000811	CcSEcCtD
Glimepiride—Hypertension—Prednisone—systemic scleroderma	0.00079	0.000811	CcSEcCtD
Glimepiride—Headache—Lisinopril—systemic scleroderma	0.000787	0.000809	CcSEcCtD
Glimepiride—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000779	0.0008	CcSEcCtD
Glimepiride—Anxiety—Prednisone—systemic scleroderma	0.000776	0.000797	CcSEcCtD
Glimepiride—Erythema—Methotrexate—systemic scleroderma	0.000764	0.000785	CcSEcCtD
Glimepiride—Malnutrition—Methotrexate—systemic scleroderma	0.000764	0.000785	CcSEcCtD
Glimepiride—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000753	0.000774	CcSEcCtD
Glimepiride—Nausea—Lisinopril—systemic scleroderma	0.000746	0.000767	CcSEcCtD
Glimepiride—Anaphylactic shock—Prednisone—systemic scleroderma	0.000746	0.000767	CcSEcCtD
Glimepiride—Shock—Prednisone—systemic scleroderma	0.000734	0.000754	CcSEcCtD
Glimepiride—Tachycardia—Prednisone—systemic scleroderma	0.000728	0.000748	CcSEcCtD
Glimepiride—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000728	0.000748	CcSEcCtD
Glimepiride—Hyperhidrosis—Prednisone—systemic scleroderma	0.000722	0.000741	CcSEcCtD
Glimepiride—Vision blurred—Methotrexate—systemic scleroderma	0.00072	0.00074	CcSEcCtD
Glimepiride—Anorexia—Prednisone—systemic scleroderma	0.000711	0.000731	CcSEcCtD
Glimepiride—Anaemia—Methotrexate—systemic scleroderma	0.000706	0.000725	CcSEcCtD
Glimepiride—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.0007	0.000719	CcSEcCtD
Glimepiride—Rash—Mycophenolate mofetil—systemic scleroderma	0.000694	0.000713	CcSEcCtD
Glimepiride—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000694	0.000712	CcSEcCtD
Glimepiride—Headache—Mycophenolate mofetil—systemic scleroderma	0.00069	0.000708	CcSEcCtD
Glimepiride—Leukopenia—Methotrexate—systemic scleroderma	0.000684	0.000703	CcSEcCtD
Glimepiride—Insomnia—Prednisone—systemic scleroderma	0.000675	0.000693	CcSEcCtD
Glimepiride—Paraesthesia—Prednisone—systemic scleroderma	0.00067	0.000688	CcSEcCtD
Glimepiride—Convulsion—Methotrexate—systemic scleroderma	0.000662	0.00068	CcSEcCtD
Glimepiride—Dyspepsia—Prednisone—systemic scleroderma	0.000657	0.000675	CcSEcCtD
Glimepiride—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000654	0.000672	CcSEcCtD
Glimepiride—Decreased appetite—Prednisone—systemic scleroderma	0.000649	0.000666	CcSEcCtD
Glimepiride—Fatigue—Prednisone—systemic scleroderma	0.000643	0.000661	CcSEcCtD
Glimepiride—Confusional state—Methotrexate—systemic scleroderma	0.000629	0.000646	CcSEcCtD
Glimepiride—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000624	0.000641	CcSEcCtD
Glimepiride—Feeling abnormal—Prednisone—systemic scleroderma	0.000615	0.000632	CcSEcCtD
Glimepiride—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000611	0.000627	CcSEcCtD
Glimepiride—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00061	0.000627	CcSEcCtD
Glimepiride—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000603	0.000619	CcSEcCtD
Glimepiride—Anorexia—Methotrexate—systemic scleroderma	0.000595	0.000611	CcSEcCtD
Glimepiride—Urticaria—Prednisone—systemic scleroderma	0.000593	0.000609	CcSEcCtD
Glimepiride—Abdominal pain—Prednisone—systemic scleroderma	0.00059	0.000606	CcSEcCtD
Glimepiride—Hypotension—Methotrexate—systemic scleroderma	0.000583	0.000599	CcSEcCtD
Glimepiride—Insomnia—Methotrexate—systemic scleroderma	0.000564	0.000579	CcSEcCtD
Glimepiride—Paraesthesia—Methotrexate—systemic scleroderma	0.00056	0.000575	CcSEcCtD
Glimepiride—Dyspnoea—Methotrexate—systemic scleroderma	0.000556	0.000571	CcSEcCtD
Glimepiride—Somnolence—Methotrexate—systemic scleroderma	0.000555	0.00057	CcSEcCtD
Glimepiride—Hypersensitivity—Prednisone—systemic scleroderma	0.00055	0.000565	CcSEcCtD
Glimepiride—Dyspepsia—Methotrexate—systemic scleroderma	0.000549	0.000564	CcSEcCtD
Glimepiride—Decreased appetite—Methotrexate—systemic scleroderma	0.000542	0.000557	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000539	0.000553	CcSEcCtD
Glimepiride—Fatigue—Methotrexate—systemic scleroderma	0.000538	0.000552	CcSEcCtD
Glimepiride—Asthenia—Prednisone—systemic scleroderma	0.000535	0.00055	CcSEcCtD
Glimepiride—Pruritus—Prednisone—systemic scleroderma	0.000528	0.000542	CcSEcCtD
Glimepiride—Feeling abnormal—Methotrexate—systemic scleroderma	0.000514	0.000528	CcSEcCtD
Glimepiride—Diarrhoea—Prednisone—systemic scleroderma	0.000511	0.000524	CcSEcCtD
Glimepiride—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00051	0.000524	CcSEcCtD
Glimepiride—Urticaria—Methotrexate—systemic scleroderma	0.000496	0.000509	CcSEcCtD
Glimepiride—Dizziness—Prednisone—systemic scleroderma	0.000494	0.000507	CcSEcCtD
Glimepiride—Abdominal pain—Methotrexate—systemic scleroderma	0.000493	0.000506	CcSEcCtD
Glimepiride—Vomiting—Prednisone—systemic scleroderma	0.000475	0.000487	CcSEcCtD
Glimepiride—Rash—Prednisone—systemic scleroderma	0.000471	0.000483	CcSEcCtD
Glimepiride—Dermatitis—Prednisone—systemic scleroderma	0.00047	0.000483	CcSEcCtD
Glimepiride—Headache—Prednisone—systemic scleroderma	0.000468	0.00048	CcSEcCtD
Glimepiride—Hypersensitivity—Methotrexate—systemic scleroderma	0.00046	0.000472	CcSEcCtD
Glimepiride—Asthenia—Methotrexate—systemic scleroderma	0.000448	0.00046	CcSEcCtD
Glimepiride—Nausea—Prednisone—systemic scleroderma	0.000443	0.000455	CcSEcCtD
Glimepiride—Pruritus—Methotrexate—systemic scleroderma	0.000441	0.000453	CcSEcCtD
Glimepiride—Diarrhoea—Methotrexate—systemic scleroderma	0.000427	0.000438	CcSEcCtD
Glimepiride—Dizziness—Methotrexate—systemic scleroderma	0.000412	0.000424	CcSEcCtD
Glimepiride—Vomiting—Methotrexate—systemic scleroderma	0.000397	0.000407	CcSEcCtD
Glimepiride—Rash—Methotrexate—systemic scleroderma	0.000393	0.000404	CcSEcCtD
Glimepiride—Dermatitis—Methotrexate—systemic scleroderma	0.000393	0.000404	CcSEcCtD
Glimepiride—Headache—Methotrexate—systemic scleroderma	0.000391	0.000401	CcSEcCtD
Glimepiride—Nausea—Methotrexate—systemic scleroderma	0.00037	0.000381	CcSEcCtD
